Characterization and purification of the bovine adrenal angiotensin IV receptor (AT4) using [125I]Benzoylphenylalanine-angiotensin IV as a specific photolabel

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 416-424

  Zhang, Jian Hua ^a   Stobb, Jeffery W ^a   Hanesworth, Jodie M ^a   Sardinia, Michael F ^a   Harding, Joseph W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II [3-8][BENZOYLPHENYLANINE I 125]; ANGIOTENSIN RECEPTOR; PROTEIN SUBUNIT; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; BINDING AFFINITY; BINDING SITE; CATTLE; CROSS LINKING; FRACTIONATION; HIPPOCAMPUS; MOLECULAR WEIGHT; NONHUMAN; PHOTOACTIVATION; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ADRENAL GLANDS; ANGIOTENSIN II; ANIMALS; CATTLE; MOLECULAR WEIGHT; PHENYLALANINE; PHOTOAFFINITY LABELS; RECEPTORS, ANGIOTENSIN;

EID: 0032463609     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Baker KM and Aceto JF (1990) Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259:H610-H618.
2. Bernier SG, Fournier A and Guillemette G (1994) A specific binding site recognizing a fragment of angiotensin II in bovine adrenal cortex membranes. Eur J Pharmacol 271:55-63.
3. Bernier SG, Servant G, Boudreau M, Fournier MA and Guillemette G (1995) Characterization of a binding site for angiotensin IV on bovine aortic endothelial cells. Eur J Pharmacol 291:191-200.
4. Blair-West JE, Coghlan JP, Denton DA, Funder JW, Scoggins BA and Wright RD (1971) The effect of the heptapeptide (2-8) and hexapeptide (3-8) fragments of angiotensin II on aldosterone secretion. J Clin Endocrinol Metab 32:575-578.
5. 1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensiin receptor. Regul Pept 44:215-223.
6. Braszko JJ, Kupryszewski G, Witczuk B and Wi'sniewski K (1988) Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rate. Neuroscience 27:777-783.
7. Coleman JKM, Krebs LT, Hamilton TA, Ong, B, Lawrence KA, Sardinia MF, Harding JW and Wright JW (1998) Autoradiographic identification of kidney angiotensin binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides 19:269-277.
8. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A and Tallant EA (1991) Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension 18[suppl III]:126-133.
9. Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL and Harding JW (1993) Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept 44:225-232.
10. Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME and Harding JW (1995) Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 58:107-115.
11. 4 receptor system in the rat kidney. Am J Physiol 274:F290-F299.
12. Hanesworth JM, Sardinia MF, Krebs LT, Hall KL and Harding JW (1993) Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes. J Pharamacol Exp Ther 266:1036-1042.
13. 4 receptors: Specificity and distribution. Kidney Int 46:1510-1512.
14. 2 recognition sites in bovine adrenal cortex. Eur J Pharmacol 219:319-322.
15. Kaiser E, Colescott RL, Bossinges CD and Cook PL (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 34:595-598.
16. Kerins DM, Hao Q and Vaughan DE (1995) Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 96:2515-2520.
17. Kramar EA, Harding JW and Wright JW (1997) Angiotensin II- and IV-induced changes in cerebral blood flow roles of AT(1), AT(2) and AT(4) receptor subtypes. Regul Pept 68:131-138.
18. 4 receptor antagonist. Regul Pept 67:123-130.
19. Lauffenburger DA and Linderman JJ (1993) Receptors, Models for Binding, Trafficking and Signaling. Oxford University Press, Inc. New York.
20. Macdonald SG, Dumas JJ and Boyd ND (1996) Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins Gq and G11. Biochemistry 35:2909-2916.
21. McNicoll N, Gagnon, J, Rondeau JJ, Ong H and De L'ean A (1996) Localization of photoaffinity labeling of natriuretic peptide receptor-A binding domain. Biochemistry 35:12950-12906.
22. Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Wright JW, Speth RC, Grove KL and Harding JW (1993) Central angiotensin IV binding sites: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 266:1718-1726.
23. 4 receptors in the Macaca fascicularis brain. Brain Res 712:307-324.
24. Moeller I, Chai SY, Oldfield BJ, McKinley MJ, Casley D and Mendelsohn FA (1995) Localization of angiotensin IV binding sites to motor and sensory neurons in the sheep spinal cord and hindbrain. Brain Res 701:301-306.
25. Peach MJ and Dostal EE (1990) The angiotensin II receptor and the actions of angiotensin II. J Cardiovasc Pharmacol 16:S25-S30.
26. Pederson ES, Foley KE, Nielson RE, Harding JW and Wright JW (1996) Attenuation of scopolamine induced memory disruption in a water maze task by an angiotensin IV analog. Soc Neurosci Abstr 22:435.
27. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning: A laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
28. 4 receptor binding characteristics: D-amino acid- and glycine substituted peptides. Peptides 14:949-954.
29. 4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues. Peptides 15:1399-1406.
30. Sealfon, S (1995) Methods in Neuroscience, Vol. 25: Receptor Molecular Biology, Academic Press, San Diego, CA.
31. 1 hippocampal lesions, or perforant pathway knife transections, on spatial memory in the rat. Soc Neurosci Abstr 22:679.
32. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC and Harding JW (1992) Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 40:409-419.
33. Thiele C and Fahrenholz, F (1993) Photoaffinity labeling of central cholecystokinin receptors with high efficiency. Biochemistry 32:2741-2746.
34. Timmermans PB, Wong PC, Chiu AT and Herblin WF (1991) Nonpeptide angiotensin II receptor antagonists. TiPS 12:55-62.
35. Tonnaer JA, Wiegant VM and De-Jong W (1982a) Subcellular localization in rat brain of angiotensin I-generating endopeptidase activity distinct from cathepsin D. J Neurochem 38:1356-1364.
36. Tonnaer JA, Wiegant VM, De-Jong W and De-Wied D (1982b) Central effects of angiotensins on drinking and blood pressure: Structure-activity relationships. Brain Res 236:417-428.
37. Wright JW, Krebs LT, Stobb JW and Harding JW (1995) The angiotensin IV system: Functional implications. Frontiers in Neuroendocrinology 16:23-52.
38. Wright JW, Miller-Wing AV, Shaffer MJ, Higginson, C, Wright DE, Hanesworth JM and Harding JW (1993) Angiotensin II(3-8) (ANG IV) hippocampal binding: Potential role in the facilitation of memory. Brain Res Bull 32:497-502.
39. 4 receptor stimulation reduces mechanically induced immediate-early gene expression in the isolated rabbit heart. Reg Peptides 81:185-193.